Testicular involvement in rheumatoid vasculitis

Clinical and Experimental Rheumatology

Volumn 22, Issue 6 SUPPL., 2004, Pages

  Mayer, Dean F ^a   Matteson, Eric L ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Rheumatoid arthritis; Rheumatoid vasculitis; Testicle; Vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; ALBUMIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; EDEMA; ELECTROMYOGRAPHY; HOSPITALIZATION; HUMAN; JOINT STIFFNESS; LABORATORY TEST; MALE; MONONEUROPATHY MULTIPLEX; MUSCLE WEAKNESS; NERVE BIOPSY; PARESTHESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADICULOPATHY; RHEUMATOID ARTHRITIS; SENSORY DYSFUNCTION; SURAL NERVE; TESTIS DISEASE; TREATMENT OUTCOME; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; TESTIS; VASCULARIZATION; VASCULITIS; HUMAN TISSUE; ORCHIECTOMY; PYURIA; RHEUMATOID VASCULITIS; SCROTAL PAIN; SKIN BIOPSY; URINALYSIS;

ADMINISTRATION, ORAL; ARTHRITIS, RHEUMATOID; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; TESTIS; TREATMENT OUTCOME; VASCULITIS;

EID: 15044357142     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. TANGNEY NJ: Testicular complications in connective tissue disease. Arch Dis Child 1981; 56: 651-2.
2. TURESSON C, O'FALLON WM, CROWSON CS, GABRIEL SE, MATTESON EL: Extraarticular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003 Aug; 62: 722-7.
3. SCHNEIDER HA, YONKER RA, KATZ P, LONGLEY S, PANUSH RS: Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum 1985 May; 14: 280-6.
4. VOLLERTSEN RS, CONN DL: Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am 1990 May; 16: 445-61.
5. TURESSON C, O'FALLON WM, CROWSON C, GABRIEL SE, MATTESON EL: Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002; 29: 62-7.
6. VOSKUYL AE, ZWINDERMAN AH, WESTEDT ML, VANDENBROUCKE JP, BREEDVELD FC, HAZES JM: The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum 1996 Feb; 39: 266-71.
7. VOSKUYL AE, ZWINDERMAN AH, WESTEDT ML, VANDENBROUCKE JP, BREEDVELD FC, HAZES JM: Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996 Mar; 55: 190-2.
8. MESSIAEN T, M'BAPPE P, BOFFA JJ et al.: MPO-ANCA necrotizing glomerulonephritis related to rheumatoid arthritis. Am J Kidney Dis 1998 Nov; 32: E6.
9. COREMANS IE, HAGEN EC, DAHA MR et al.: Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992 Dec; 35: 1466-75.
10. WEYAND CM, XIE C, GORONZY JJ: Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992 Jun; 89: 2033-9.
11. NICHOLLS A, SNAITH ML, MAINI RN, SCOTT JT: Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis 1973 Nov; 32: 589-91.
12. FLIPO RM, CARDON T, COPIN MC, VANDECANDELAERE M, DUQUESNOY B, JANIN A: ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis. Ann Rheum Dis 1997 Jan; 56: 41-4.
13. RICHTER C, WANKE L, STEINMETZ J, REINHOLD-KELLER E, GROSS WL: Mononeuritis secondary to rheumatoid arthritis responds to etanercept. Rheumatology (Oxford) 2000; 39: 1436-7.
14. DEN BROEDER AA, VAN DEN HOOGEN FH, VAN DE PUTTE LB: Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment. Ann Rheum Dis 2001 May; 60: 538-9.
15. BARTOLUCCI P, RAMANOELINA J, COHEN P et al.: Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford). 2002; 41: 1126-32.
16. UNGER L, KAYSER M, NUSSLEIN HG: Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 2003; 62: 587-8.